Jungk Christine, Mock Andreas, Exner Janina, Geisenberger Christoph, Warta Rolf, Capper David, Abdollahi Amir, Friauf Sara, Lahrmann Bernd, Grabe Niels, Beckhove Philipp, von Deimling Andreas, Unterberg Andreas, Herold-Mende Christel
Division of Experimental Neurosurgery, Department of Neurosurgery, Ruprecht-Karls-University Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Department of Neuropathology, Heidelberg University Hospital; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
BMC Med. 2016 Oct 26;14(1):170. doi: 10.1186/s12916-016-0710-7.
The spatial relationship of glioblastoma (GBM) to the subventricular zone (SVZ) is associated with inferior patient survival. However, the underlying molecular phenotype is largely unknown. We interrogated an SVZ-dependent transcriptome and potential location-specific prognostic markers.
mRNA microarray data of a discovery set (n = 36 GBMs) were analyzed for SVZ-dependent gene expression and process networks using the MetaCore™ workflow. Differential gene expression was confirmed by qPCR in a validation set of 142 IDH1 wild-type GBMs that was also used for survival analysis.
Microarray analysis revealed a transcriptome distinctive of SVZ+ GBM that was enriched for genes associated with Notch signaling. No overlap was found to The Cancer Genome Atlas's molecular subtypes. Independent validation of SVZ-dependent expression confirmed four genes with simultaneous prognostic impact: overexpression of HES4 (p = 0.034; HR 1.55) and DLL3 (p = 0.017; HR 1.61) predicted inferior, and overexpression of NTRK2 (p = 0.049; HR 0.66) and PIR (p = 0.025; HR 0.62) superior overall survival (OS). Additionally, overexpression of DLL3 was predictive of shorter progression-free survival (PFS) (p = 0.043; HR 1.64). Multivariate analysis revealed overexpression of HES4 to be independently associated with inferior OS (p = 0.033; HR 2.03), and overexpression of DLL3 with inferior PFS (p = 0.046; HR 1.65).
We identified four genes with SVZ-dependent expression and prognostic significance, among those HES4 and DLL3 as part of Notch signaling, suggesting further evaluation of location-tailored targeted therapies.
胶质母细胞瘤(GBM)与脑室下区(SVZ)的空间关系与患者较差的生存率相关。然而,其潜在的分子表型在很大程度上尚不清楚。我们研究了一种依赖SVZ的转录组和潜在的位置特异性预后标志物。
使用MetaCore™工作流程分析了一个发现集(n = 36个GBM)的mRNA微阵列数据,以确定依赖SVZ的基因表达和过程网络。通过qPCR在142个IDH1野生型GBM的验证集中确认差异基因表达,该验证集也用于生存分析。
微阵列分析揭示了一种SVZ + GBM独特的转录组,该转录组富含与Notch信号相关的基因。未发现与癌症基因组图谱的分子亚型有重叠。对依赖SVZ的表达进行独立验证,确认了四个具有同时预后影响的基因:HES4(p = 0.034;HR 1.55)和DLL3(p = 0.017;HR 1.61)的过表达预示较差的总体生存率(OS),而NTRK2(p = 0.049;HR 0.66)和PIR(p = 0.025;HR 0.62)的过表达预示较好的总体生存率。此外,DLL3的过表达预示无进展生存期(PFS)较短(p = 0.043;HR 1.64)。多变量分析显示,HES4的过表达与较差的OS独立相关(p = 0.033;HR 2.03),而DLL3的过表达与较差的PFS独立相关(p = 0.046;HR 1.65)。
我们鉴定出四个具有依赖SVZ表达和预后意义的基因,其中HES4和DLL3作为Notch信号的一部分,提示进一步评估针对特定位置的靶向治疗。